The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
Now Live: Breaking Research From AIDS 2008: Podcasts, Interviews, Videos & More >>
Index of Articles From 1994 TAGlines

1994 TAGlines logo
  • December, 1994
    • Protease Scoreboard
      Planning for Efficacy Rates of 30-50%, Roche Protease Trials Shoot for Distant Stars
    • The Imperiled NCDDG
      Twilight of NIH Drug Discovery Program Will Mean Even Slimmer Pickings for AIDS Therapeutic Pipeline
    • Random Gleanings Vaccine Victory (Of Sorts), Inching Closer To An Animal Model for HIV, G.D. Searle's lead protease inhibitor crashed and burned...

  • November, 1994
  • October, 1994
    • Star Gazing at the FDA
      Public Hearings At FDA Juxtapose Old Cries of Access With Those of Integrity, Accountability
    • Yokohama Pathogenesis Update
      Improved Clinical Outcomes Wrought By Immunosuppressive Medicine and Second-Rate Immune Responses - Where Will It All End?
    • The KS Project Report
      Research Paper Details Advances, Obstacles In The Treatment of Kaposi's Sarcoma

  • September, 1994
  • August, 1994
    • Shiftless Cytokines
      Series of Research Papers Take To Task Would-Be Discoverers Of Cytokine Switch Scrutinizing the Knock-out Mice
    • The Body in Question
      Garbage In, Garbage Out; Could It Be We're Asking Good Questions Of Bad Systems?
    • Letter From Rockville
      Another meeting with the (FDA) Commissioner, Rockville, MD, 11 July 1994

  • July, 1994
    • Not So Fast!
      With Its First Protease Trial Completed, Roche Races to FDA With Lukewarm Results, While Activists Cry 'Foul'
    • Vaccine Dismay
      NIAID Scraps Large Scale Vaccine Trial -- And A Chastened Genentech Takes Its Case to The Hill
    • ACTG Rescue Plan
      Tome of Recommendations Would Abolish ACDDC, Mandate Costing-Out and Establish Advisory Review Group
    • A Word About TAG
      Information about TAG

  • June, 1994
    • ACTG: Feet to the Fire
      Feet to the Fire, ACTG Investigators Scramble to Convince Industry They Can Produce
    • The Intra-Company Cooperative
      ICC's Brainchild Designed to Show Every Drug and Every Combination a Success. Who Could Complain About That?
    • d4T Approval Looms
      Accelerated Approval Guidelines Expedite Bristol's Launch of New Nucleoside -- In the Absence of Any Proof That It Works

  • May, 1994


Back to the Treatment Action Group index page